Event List
retrieve:
Return the details about the given Event id.
list:
List all Event objects.
GET /api/v1/events/?format=api&offset=210&ordering=-event__start_time
{ "count": 217, "next": null, "previous": "https://memento.epfl.ch/api/v1/events/?format=api&limit=10&offset=200&ordering=-event__start_time", "results": [ { "id": 71899, "title": "Registration deadline: CREApoly – Collective Expressions", "slug": "registration-deadline-creapoly-collective-expressi", "event_url": "https://memento.epfl.ch/event/registration-deadline-creapoly-collective-expressi", "visual_url": "https://memento.epfl.ch/image/33217/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33217/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33217/max-size.jpg", "lang": "en", "start_date": "2026-05-18", "end_date": "2026-06-30", "start_time": null, "end_time": null, "description": "<p>EPFL invites its staff and doctoral students to exhibit their artistic works (paintings, ceramics, framed works on paper, textile art, sculpture, mixed media; no photographs or videos) as part of the CREApoly exhibition. This exhibition offers a space for free, creative, and non-judgmental expression where you can share your artistic vision.<br>\r\n<br>\r\nA community-focused initiative organized as part of the 2026 <a href=\"https://jours-sante.ch/en/\"><strong>Health days</strong></a> and <strong><a href=\"https://www.epfl.ch/campus/art-culture/les-culturelles-cultural-week/\">Les Culturelles Festival</a></strong>.<br>\r\n<br>\r\n<strong>Practical Information:</strong>\r\n</p><ul>\r\n\t<li>Exhibition at the <a href=\"https://plan.epfl.ch/?room==SG%20294.22\">Foyer SG</a> (1st floor of the Architecture Building)</li>\r\n\t<li>Opening : Thursday, October 8 at 6:30 p.m.</li>\r\n\t<li>Exhibition dates: October 9–12, 2026</li>\r\n\t<li>Submission deadline: Tuesday, June 30, 2026, at midnight</li>\r\n\t<li>Open to EPFL staff and doctoral students</li>\r\n</ul>\r\n<strong>Join us!</strong><br>\r\nWant to contribute to this event dedicated to creativity and sharing? Sign up now using the <a href=\"https://forms.office.com/e/iLTQTREgrE?utm_medium=email&utm_campaign=CreaPoly+2026+-+Appel+%C3%A0+participation+%2F%2F%2F+Call+for+participation&utm_source=CreaPoly+2026+-+Appel+%C3%A0+participation+%2F%2F%2F+Call+for+participation&utm_content=Remplir+le+formulaire\">registration form</a>.<br>\r\n<br>\r\n<strong>PDF application to be attached:</strong> A maximum of two pages is required, including:\r\n\r\n<ul>\r\n\t<li>One or two proposals for works to be exhibited, created using one of the following techniques: ceramics, painting, works on paper (framed), textile art, sculpture, or mixed media. Photographic and video works are not eligible.</li>\r\n\t<li>A paragraph describing your artistic approach</li>\r\n\t<li>A complete description for each artwork (title, date, medium, dimensions, weight, insurance value)</li>\r\n\t<li>A photograph of each artwork</li>\r\n\t<li>A biographical note (optional)</li>\r\n</ul>\r\n<strong>Registration closes at midnight on Tuesday, June 30<br>\r\n<a href=\"https://forms.office.com/e/iLTQTREgrE?utm_medium=email&utm_campaign=CreaPoly+2026+-+Appel+%C3%A0+participation+%2F%2F%2F+Call+for+participation&utm_source=CreaPoly+2026+-+Appel+%C3%A0+participation+%2F%2F%2F+Call+for+participation&utm_content=Remplir+le+formulaire\">>>> Registration form</a></strong>", "image_description": "", "creation_date": "2026-05-18T16:53:12", "last_modification_date": "2026-05-20T13:58:47", "link_label": "CREApoly 2026", "link_url": "https://www.epfl.ch/campus/art-culture/fr/accueil/creapoly-collective-expressions/", "canceled": "False", "cancel_reason": "", "place_and_room": "Foyer SG", "url_place_and_room": "https://plan.epfl.ch/?room==SG%20294.22", "url_online_room": "", "spoken_languages": [], "speaker": "EPFL staff and doctoral students", "organizer": "Pôle culture EPFL", "contact": "<a href=\"https://people.epfl.ch/tina.karati\">Tina Karati</a>", "is_internal": "True", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 1, "fr_label": "Sur inscription", "en_label": "Registration required" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120795/", "category": { "id": 5, "code": "EXPO", "fr_label": "Expositions", "en_label": "Exhibitions", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/1/?format=api", "https://memento.epfl.ch/api/v1/mementos/5/?format=api", "https://memento.epfl.ch/api/v1/mementos/6/?format=api", "https://memento.epfl.ch/api/v1/mementos/8/?format=api", "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/21/?format=api", "https://memento.epfl.ch/api/v1/mementos/22/?format=api", "https://memento.epfl.ch/api/v1/mementos/27/?format=api", "https://memento.epfl.ch/api/v1/mementos/145/?format=api", "https://memento.epfl.ch/api/v1/mementos/396/?format=api", "https://memento.epfl.ch/api/v1/mementos/425/?format=api" ] }, { "id": 71900, "title": "U.S. CDMRP – Breast Cancer Research Program | Research Funding", "slug": "us-cdmrp-breast-cancer-research-program-research-5", "event_url": "https://memento.epfl.ch/event/us-cdmrp-breast-cancer-research-program-research-5", "visual_url": "https://memento.epfl.ch/image/33218/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33218/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33218/max-size.jpg", "lang": "en", "start_date": "2026-06-12", "end_date": "2026-06-12", "start_time": null, "end_time": null, "description": "<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Breast Cancer Research Program</strong> <strong>(BCRP)</strong> Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Breakthrough Awards</strong> supports promising research that has high potential to lead to or make breakthroughs in breast cancer. The Breakthrough Award is structured with four different funding levels. Each level has a defined research scope :\r\n\t<ul>\r\n\t\t<li><u>Funding Level 1</u>: Innovative, high-risk/high-reward research that is in the earliest stages of idea development or is an untested theory that addresses an important problem.</li>\r\n\t\t<li><u>Funding Level 2</u>: Research that is already supported by substantial preliminary or published data and strongly validates clinical translation in a well-defined context within the breast cancer landscape.</li>\r\n\t\t<li><u>Funding Level 3</u><strong>: </strong>Advanced translational studies with a high degree of project readiness.</li>\r\n\t\t<li><u>Funding Level 4</u><strong>: </strong>Large-scale projects that will transform and revolutionize the clinical management and/or prevention of breast cancer. Human clinical trials are required.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>The <strong>Clinical Research Extension Award</strong> aims to extend the data collection, follow-up, and analysis of breast cancer clinical research studies. Proposed research may entail a deeper molecular analysis of clinical samples, initiation of new correlative studies, biomarker validation, or continuing clinical follow-up of patients currently/previously enrolled in an open/ongoing or completed clinical trial.</li>\r\n\t<li>The <strong>Era of Hope Scholar Award</strong> supports individuals early in their careers who have demonstrated significant potential to effect meaningful change in breast cancer. These individuals should be exceptionally talented scientists who have shown that they are the “best and brightest” in their field(s)</li>\r\n\t<li>The <strong>Transformative Breast Cancer Consortium Award</strong> is designed to support large-scale, multidisciplinary and multi-institutional consortia that address major challenges in breast cancer through tightly integrated and collaborative research efforts. It enables up to five Principal Investigators, including a Consortium Director, to work within a coordinated framework where all project components are aligned toward a shared central hypothesis. The award specifically aims to foster innovative and paradigm-shifting approaches that go beyond the capabilities of individual laboratories, requiring strong integration across scientific, administrative, and logistical aspects, as well as the active involvement of breast cancer advocates and cross-disciplinary expertise.</li>\r\n\t<li>The <strong>Transformative Breast Cancer Consortium Development Award</strong> is intended to provide successful applicants the time and resources needed to bring investigators and breast cancer advocates together to establish a consortium framework and conduct preliminary research to support application to a future, full Transformative Breast Cancer Consortium Award (pending availability of funds). This is a development award and is a separate mechanism from the full consortium award. Recipients of the FY26 Transformative Breast Cancer Consortium Development Award are expected to submit an application to compete for the full Transformative Breast Cancer Consortium Award anticipated to be offered in a future fiscal year(s).</li>\r\n</ul>\r\n<br>\r\nAll applications must align with at least one BCRP Overarching Challenge. The FY26 BCRP Challenges are listed at the end of this announcement.<br>\r\n<br>\r\n<strong>Funding</strong>: <br>\r\nBreakthrough 1: $750K - $1.25M<br>\r\nBreakthrough 2: $1.65M - $3.35M<br>\r\nBreakthrough 3: $5.6M - $7M<br>\r\nBreakthrough 4: max. $21M<br>\r\nClinical Research Extension: $7M - $8.4M<br>\r\nEra of Hope: max. $4.9M<br>\r\nTransformative Breast Cancer Consortium Award: max. $35M<br>\r\nTransformative Breast Cancer Consortium Development Award: max. $140K<br>\r\n<sub>Note: Cost caps are <strong><em>total costs (direct plus indirect costs).</em> </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding.</sub><br>\r\n<br>\r\n<strong>Duration</strong>: <br>\r\nBreakthrough 1: 3 years<br>\r\nBreakthrough 2: 3-4 years<br>\r\nBreakthrough 3: 4 years<br>\r\nBreakthrough 4: 4 years<br>\r\nClinical Research Extension: 4 years<br>\r\nEra of Hope: 4 years<br>\r\nTransformative Breast Cancer Consortium Award: 4 years<br>\r\nTransformative Breast Cancer Consortium Development Award: 1 year<br>\r\n<br>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Programme-specific seniority levels are further defined <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241307&fileType=pdf\">here</a>.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: </strong>\r\n\r\n<ul>\r\n\t<li><strong>12 June 2026, </strong>5:00 p.m. Eastern time\r\n\r\n\t<ul>\r\n\t\t<li>Breakthrough Award Level 3</li>\r\n\t\t<li>Breakthrough Award Level 4</li>\r\n\t\t<li>Transformative Breast Cancer Consortium Award</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><strong>24 June 2026, </strong>5:00 p.m. Eastern time\r\n\t<ul>\r\n\t\t<li>Breakthrough Award Level 1-2</li>\r\n\t\t<li>Transformative Breast Cancer Consortium Development Award</li>\r\n\t\t<li>Clinical Research Extension Award</li>\r\n\t\t<li>Era of Hope Scholar Award</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<br>\r\n<strong>Full Application Deadline</strong>: \r\n\r\n<ul>\r\n\t<li><strong>08 July 2026, </strong>11:59 p.m. Eastern time\r\n\r\n\t<ul>\r\n\t\t<li>Breakthrough Award Level 1-2</li>\r\n\t\t<li>Transformative Breast Cancer Consortium Development Award</li>\r\n\t\t<li>Clinical Research Extension Award</li>\r\n\t\t<li>Era of Hope Scholar Award</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><strong>30 September 2026, </strong>11:59 p.m. Eastern time\r\n\t<ul>\r\n\t\t<li>Breakthrough Award Level 3</li>\r\n\t\t<li>Breakthrough Award Level 4</li>\r\n\t\t<li>Transformative Breast Cancer Consortium Award</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=705101\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241307&fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:[email protected]\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Breakthrough 1: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855304&fileType=doc&otherMimeType=application/msword\">HT942526BCRPBTA12</a></li>\r\n\t\t<li>Breakthrough 2: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855304&fileType=doc&otherMimeType=application/msword\">HT942526BCRPBTA12</a></li>\r\n\t\t<li>Breakthrough 3: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855250&fileType=doc&otherMimeType=application/msword\">HT942526BCRPBTA3</a></li>\r\n\t\t<li>Breakthrough 4: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855218&fileType=doc&otherMimeType=application/msword\">HT942526BCRPBTA4</a></li>\r\n\t\t<li>Clinical Research Extension: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855261&fileType=doc&otherMimeType=application/msword\">HT942526BCRPCREA</a></li>\r\n\t\t<li>Era of Hope: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855289&fileType=doc&otherMimeType=application/msword\">HT942526BCRPEOHS</a></li>\r\n\t\t<li>Transformative Breast Cancer Consortium Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35853313&fileType=doc&otherMimeType=application/msword\">HT942526BCRPTBCCA</a></li>\r\n\t\t<li>Transformative Breast Cancer Consortium Development Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35855260&fileType=doc&otherMimeType=application/msword\">HT942526BCRPTBCCDA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<br>\r\n<strong>FY26 BCRP Overarching Challenges</strong>\r\n\r\n<ul>\r\n\t<li>Prevent breast cancer (primary prevention)</li>\r\n\t<li>Identify determinants of breast cancer initiation, risk, or susceptibility</li>\r\n\t<li>Distinguish deadly from non-deadly breast cancers</li>\r\n\t<li>Conquer the problems of overdiagnosis and overtreatment</li>\r\n\t<li>Identify what drives breast cancer growth; determine how to stop it</li>\r\n\t<li>Identify why some breast cancers become metastatic</li>\r\n\t<li>Determine why/how breast cancer cells lie dormant for years and then re-emerge; determine how to prevent lethal recurrence</li>\r\n\t<li>Revolutionize treatment regimens by replacing them with ones that do all of the following: improve survival, are more effective, and are less toxic</li>\r\n\t<li>Eliminate the mortality associated with metastatic breast cancer</li>\r\n</ul>\r\nAlternatively, with adequate justification, applications may identify and address another overarching challenge related to <a href=\"https://cdmrp.health.mil/bcrp/pdfs/BreastCancerLandscape2025.pdf\">The Breast Cancer Landscape</a>. Justification must be provided in the application.<br>\r\n ", "image_description": "", "creation_date": "2026-05-18T19:01:58", "last_modification_date": "2026-05-18T19:01:58", "link_label": "", "link_url": "", "canceled": "False", "cancel_reason": "", "place_and_room": "", "url_place_and_room": "", "url_online_room": "", "spoken_languages": [ "https://memento.epfl.ch/api/v1/spoken_languages/2/?format=api" ], "speaker": "", "organizer": "", "contact": "<a href=\"mailto:[email protected]\">Research Office</a>", "is_internal": "False", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 3, "fr_label": "Entrée libre", "en_label": "Free" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120797/", "category": { "id": 16, "code": "PROP", "fr_label": "Appel à proposition", "en_label": "Call for proposal", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/140/?format=api" ] }, { "id": 71906, "title": "Workshop for Postdocs on the Creative Scientific Process", "slug": "workshop-for-postdocs-on-the-creative-scientific-p", "event_url": "https://memento.epfl.ch/event/workshop-for-postdocs-on-the-creative-scientific-p", "visual_url": "https://memento.epfl.ch/image/33223/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33223/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33223/max-size.jpg", "lang": "en", "start_date": "2026-06-25", "end_date": "2026-06-25", "start_time": null, "end_time": null, "description": "<p>Are you finding it difficult to come up with a truly innovative idea for your next grant application? Do you ever feel stuck in an experiment, in familiar ways of thinking, even when you <em>know</em> there must be new angles to explore?<br>\r\n<br>\r\nScience progress moves between two complementary modes: <em>Day Science</em>, the rigorous testing of ideas, and <em>Night Science</em>, the creative process where those ideas first emerge. Indeed, what we call the scientific method tells us what to do once we have a hypothesis – but where do these hypotheses come from in the first place? François Jacob famously called this part the realm of ‘<em>Night Science’</em>.<br>\r\n<br>\r\nDrawing on the <a href=\"https://night-science.org/home/learn/\">Night Science training framework</a> developed by Profs Itai Yanai and Martin Lercher, this workshop will introduce thinking tools and exercises to help you foster exploratory thinking, interdisciplinarity and a general attitude of openness towards new ideas applied to your own research challenges. This course is provided by a certified Night Science trainer from the <a href=\"https://www.epfl.ch/research/services/units/research-office/\" target=\"_blank\">EPFL Research Office</a>. <br>\r\n<br>\r\n<strong>This interactive workshop is designed specifically for postdoctoral researchers who want to:</strong>\r\n</p><ul>\r\n\t<li>Generate novel, high-risk/high-reward ideas for grants and publications</li>\r\n\t<li>Overcome conceptual or experimental roadblocks</li>\r\n\t<li>Expand their thinking beyond conventional frameworks</li>\r\n\t<li>Reconnect with the creative side of the scientific process</li>\r\n</ul>\r\n<strong><em>When and Where</em></strong><strong>:</strong> June 25, 2026, 08:30-14:00. On-site only, room <a href=\"https://plan.epfl.ch/?dim_floor=0&lang=en&dim_lang=en&tree_groups=centres_nevralgiques_grp%2Cmobilite_acces_grp%2Crestauration_et_commerces_grp%2Censeignement%2Cservices_campus_grp%2Cequipements_grp&tree_group_layers_centres_nevralgiques_grp=&tree_group_layers_mobilite_acces_grp=metro&tree_group_layers_restauration_et_commerces_grp=&tree_group_layers_enseignement=guichet_etudiants&tree_group_layers_services_campus_grp=information_epfl&tree_group_layers_equipements_grp=&baselayer_ref=grp_backgrounds&map_x=2533099&map_y=1152409&map_zoom=14\">MED0 1618</a> (Lausanne campus). Lunch provided.<br>\r\n<br>\r\n<strong><em>Programme:</em></strong>\r\n\r\n<ul>\r\n\t<li><strong>08:30-08:45 : </strong>Breakfast + Welcome coffee </li>\r\n\t<li><strong>08:45-10:15 : </strong>Session 1: Night science, openness, improvisation, takes two to think + Exercise</li>\r\n\t<li><strong>10:15-10:30</strong> :Coffee break</li>\r\n\t<li><strong>10:30-12:00</strong> : Session 2: Import/export, 2 languages + Exercise</li>\r\n\t<li><strong>12:00-12:30</strong> : Lunch</li>\r\n\t<li><strong>12:30-13:30</strong> : Session 3: Hypothesis is a liability, what’s the question + Exercise</li>\r\n\t<li><strong>13:30-14:00</strong> : Wrap-up Discussion </li>\r\n</ul>\r\n<br>\r\n<strong><em>Registration</em></strong><strong>:</strong> Participation limited to <strong>30 attendees</strong>, on a first-come first-served basis. Register early to secure your spot <a href=\"https://forms.office.com/Pages/ResponsePage.aspx?id=alXC9vvEsUqix54iDfEcQzE88_YGNxJDjy6KyYIGmdJURE5VSVdLN1YxTFVJQVAxVFoxREJQR0YyNCQlQCN0PWcu\">here</a>. A waiting list will be organised.<br>\r\n<br>\r\n<u>Registration will close on June 18<sup>th</sup> after which attendance will be confirmed by email</u>.<br>\r\n <br>\r\nAny questions? Contact the Research Office at <a href=\"mailto:[email protected]\">[email protected]</a>.", "image_description": "", "creation_date": "2026-05-19T12:24:26", "last_modification_date": "2026-05-19T12:32:09", "link_label": "", "link_url": "", "canceled": "False", "cancel_reason": "", "place_and_room": "", "url_place_and_room": "", "url_online_room": "", "spoken_languages": [], "speaker": "", "organizer": "", "contact": "<a href=\"mailto:[email protected]?subject=Workshop%20for%20Postdocs%20on%20the%20Creative%20Scientific%20Process\">Research Office</a>", "is_internal": "False", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 3, "fr_label": "Entrée libre", "en_label": "Free" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120804/", "category": { "id": 1, "code": "CONF", "fr_label": "Conférences - Séminaires", "en_label": "Conferences - Seminars", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/1/?format=api", "https://memento.epfl.ch/api/v1/mementos/3/?format=api", "https://memento.epfl.ch/api/v1/mementos/5/?format=api", "https://memento.epfl.ch/api/v1/mementos/6/?format=api", "https://memento.epfl.ch/api/v1/mementos/8/?format=api", "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/27/?format=api", "https://memento.epfl.ch/api/v1/mementos/140/?format=api" ] }, { "id": 71922, "title": "U.S. CDMRP – Alzheimer's Research Program | Research Funding", "slug": "us-cdmrp-alzheimer-s-research-program-research-fun", "event_url": "https://memento.epfl.ch/event/us-cdmrp-alzheimer-s-research-program-research-fun", "visual_url": "https://memento.epfl.ch/image/33239/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33239/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33239/max-size.jpg", "lang": "en", "start_date": "2026-06-22", "end_date": "2026-06-22", "start_time": null, "end_time": null, "description": "<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Alzheimer's Research Program (AZRP) </strong>Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Transforming Care Award </strong>aims to support well-designed, non-incremental clinical research that develops and implements interventions, innovations, and solutions to address critical challenges in dementia care. Projects should lead to improved quality of life, reduced caregiver burden and stress, and enhanced care delivery and outcomes for individuals living with AD/ADRD.</li>\r\n\t<li>The <strong>Transforming Diagnosis Award </strong>supports non-incremental, solution-oriented research that addresses critical barriers to timely and accurate diagnosis, disease monitoring, and prognosis in AD/ADRD. Projects should demonstrate clear potential to improve accessibility, clinical implementation, and the reliability of diagnostic and prognostic approaches.</li>\r\n\t<li>The <strong>Transforming Research Award </strong>supports non-incremental, high-impact research that aims to drive transformative advances in reducing risk and preventing the development of AD/ADRD. Projects should demonstrate strong potential to accelerate prevention strategies and deliver meaningful improvements in patient outcomes and quality of life.<strong> </strong>All projects must respond to one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241238&fileType=pdf\">here</a>.</li>\r\n</ul>\r\n<strong>Funding</strong>:\r\n\r\n<ul>\r\n\t<li>Transforming Care Award: $1.6M - $1.9M</li>\r\n\t<li>Transforming Diagnosis Award: $1.5M - $1.7M</li>\r\n\t<li>Transforming Research Award: max. $1M</li>\r\n</ul>\r\n<br>\r\n<sub>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sub><br>\r\n<br>\r\n<br>\r\n<strong>Duration</strong>: \r\n\r\n<ul>\r\n\t<li>Transforming Care Award: 4 years</li>\r\n\t<li>Transforming Diagnosis Award: 4 years</li>\r\n\t<li>Transforming Research Award: 3 years</li>\r\n</ul>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Program-specific seniority levels and eligibility criteria are further defined within each award mechanism <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36243245&fileType=pdf\">here</a>.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 22 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>24 September 2026</strong>, 11:59 p.m Eastern Time<br>\r\n<br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719106\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36243245&fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:[email protected]\">Research Office</a></li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Transforming Care Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241229&fileType=pdf\">HT942526AZRPTRCA</a></li>\r\n\t\t<li>Transforming Diagnosis Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241231&fileType=pdf\">HT942526AZRPTRDA</a></li>\r\n\t\t<li>Transforming Research Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241238&fileType=pdf\">HT942526AZRPTRRA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>", "image_description": "", "creation_date": "2026-05-21T16:12:42", "last_modification_date": "2026-05-21T16:12:42", "link_label": "", "link_url": "", "canceled": "False", "cancel_reason": "", "place_and_room": "", "url_place_and_room": "", "url_online_room": "", "spoken_languages": [ "https://memento.epfl.ch/api/v1/spoken_languages/2/?format=api" ], "speaker": "", "organizer": "", "contact": "<a href=\"mailto:[email protected]\">Research Office</a>", "is_internal": "False", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 3, "fr_label": "Entrée libre", "en_label": "Free" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120829/", "category": { "id": 16, "code": "PROP", "fr_label": "Appel à proposition", "en_label": "Call for proposal", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/140/?format=api" ] }, { "id": 71948, "title": "U.S. CDMRP – Lung Cancer Research Program | Research Funding", "slug": "us-cdmrp-lung-cancer-research-program-research-f-6", "event_url": "https://memento.epfl.ch/event/us-cdmrp-lung-cancer-research-program-research-f-6", "visual_url": "https://memento.epfl.ch/image/33256/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33256/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33256/max-size.jpg", "lang": "en", "start_date": "2026-06-23", "end_date": "2026-06-23", "start_time": null, "end_time": null, "description": "<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Lung Cancer Research Program</strong> <strong>(LCRP)</strong> Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Idea Development Award</strong> Supports new ideas in the early stages of development representing innovative, high-risk/high-gain research.</li>\r\n\t<li>The <strong>Patient-Centered Outcomes and Survivorship Award</strong> Supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications.</li>\r\n\t<li>The <strong>Translational Research Award</strong> mechanism supports advanced translational research that will foster transformation of promising ideas in lung cancer into clinical applications. Translational research may be defined as an integration of basic science and clinical observations. Observations that drive a research idea may originate from a laboratory discovery, population-based studies, or a clinician’s firsthand knowledge of patient care. The ultimate goal of translational research is to move a concept or observation forward into clinical application.</li>\r\n</ul>\r\nAll applications for LCRP funding must specifically address at least one of the <strong>Areas of Emphasis</strong>. The FY26 LCRP Areas are listed at the end of this announcement.<br>\r\n<br>\r\n<strong>Funding</strong>: <br>\r\nIdea Development Award: max. $800K<br>\r\nPatient-Centered Outcomes and Survivorship Award: max. $975K<br>\r\nTranslational Research Award: $1.35M – $1.85M<br>\r\n<sup><sub>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sub></sup><br>\r\n<br>\r\n<strong>Duration</strong>: <br>\r\nIdea Development Award: 3 years<br>\r\nPatient-Centered Outcomes and Survivorship Award: 3 years<br>\r\nTranslational Research Award: 3-4 years<br>\r\n<br>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Program-specific seniority levels and eligibility criteria are further defined within each award mechanism <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221239&fileType=pdf\">here</a>.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: </strong>\r\n\r\n<ul>\r\n\t<li><strong>23 June 2026, </strong>5:00 p.m. Eastern time\r\n\r\n\t<ul>\r\n\t\t<li>Idea Development Award</li>\r\n\t\t<li>Translational Research Award</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><strong>18 August 2026, </strong>5:00 p.m. Eastern time\r\n\t<ul>\r\n\t\t<li>Patient-Centered Outcomes and Survivorship Award</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<strong>Full Application Deadline for all calls</strong>:\r\n\r\n<ul>\r\n\t<li><strong>02 September 2026</strong>, 11:59 p.m Eastern Time</li>\r\n</ul>\r\n <br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719103\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221239&fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:[email protected]\">Research Office</a></li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Idea Development Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221233&fileType=pdf\">HT942526LCRPIDA</a></li>\r\n\t\t<li>Patient-Centered Outcomes and Survivorship Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221308&fileType=pdf\">HT942526LCRPPCOSA</a></li>\r\n\t\t<li>Translational Research Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36221292&fileType=pdf\">HT942526LCRPTRA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<br>\r\n<strong>FY26 LCRP Areas of Emphasis</strong>\r\n\r\n<ul>\r\n\t<li>Biology and Etiology\r\n\t<ul>\r\n\t\t<li>Understand the molecular mechanisms of initiation and progression of pre-malignancy to lung cancer.</li>\r\n\t\t<li>Understand contributors to lung cancer development other than tobacco, including hereditary and sex-specific differences.</li>\r\n\t\t<li>Understand the biology of metastatic/oligometastatic disease progression.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Prevention and Risk Reduction\r\n\t<ul>\r\n\t\t<li>Identify innovative strategies for the prevention and/or interception of lung cancer development.</li>\r\n\t\t<li>Identify innovative strategies for the prevention of recurrence or metastases from lung cancer.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Detection, Diagnosis and Surveillance\r\n\t<ul>\r\n\t\t<li>Improve and expand approaches to screening and early detection of lung cancer.</li>\r\n\t\t<li>Identify strategies for prompt detection and/or characterization of progressive disease.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Treatment and Prognosis\r\n\t<ul>\r\n\t\t<li>Identify innovative strategies for the treatment of lung cancer, including overcoming resistance.</li>\r\n\t\t<li>Develop or optimize biomarkers to assist with therapeutic decision-making.</li>\r\n\t\t<li>Enhance the understanding, detection, and treatment of brain and leptomeningeal metastases in lung cancer.</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li>Health Outcomes and Survivorship\r\n\t<ul>\r\n\t\t<li>Identify and understand the long-term and cumulative effects of lung cancer and its treatment(s) on quality of life for patients and families.</li>\r\n\t\t<li>Identify and understand the impact of comorbidities on survivorship care in all stages of lung cancer.</li>\r\n\t\t<li>Reduce differences among high-risk groups and populations.</li>\r\n\t</ul>\r\n\t</li>\r\n</ul>", "image_description": "", "creation_date": "2026-05-26T19:15:50", "last_modification_date": "2026-05-26T19:15:50", "link_label": "", "link_url": "", "canceled": "False", "cancel_reason": "", "place_and_room": "", "url_place_and_room": "", "url_online_room": "", "spoken_languages": [ "https://memento.epfl.ch/api/v1/spoken_languages/2/?format=api" ], "speaker": "", "organizer": "", "contact": "<a href=\"mailto:[email protected]\">Research Office</a>", "is_internal": "False", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 3, "fr_label": "Entrée libre", "en_label": "Free" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120861/", "category": { "id": 16, "code": "PROP", "fr_label": "Appel à proposition", "en_label": "Call for proposal", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/140/?format=api" ] }, { "id": 71949, "title": "U.S. CDMRP – Amyotrophic Lateral Sclerosis Research Program | Research Funding", "slug": "us-cdmrp-amyotrophic-lateral-sclerosis-research--4", "event_url": "https://memento.epfl.ch/event/us-cdmrp-amyotrophic-lateral-sclerosis-research--4", "visual_url": "https://memento.epfl.ch/image/33257/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33257/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33257/max-size.jpg", "lang": "en", "start_date": "2026-06-24", "end_date": "2026-06-24", "start_time": null, "end_time": null, "description": "<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Amyotrophic Lateral Sclerosis Research Program (ALSRP) </strong>Awards. Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Clinical Outcomes and Biomarkers Award </strong>supports the development and/or validation of clinical outcomes and biomarkers to enrich clinical trials in Amyotrophic Lateral Sclerosis (ALS). Projects can be relevant to a specific therapy, a class of therapeutics, or to a specific ALS subtype (such as a particular genetic mutation) and do not have to broadly apply to all patients. Applications must address at least one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35925310&fileType=pdf\">here</a>.</li>\r\n\t<li>The <strong>Pilot Clinical Trial Award </strong>supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or symptom management of ALS. Proposed projects may range from phase 1 to small-scale phase 2 trials. Applications must address at least one of the focus areas listed <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35927287&fileType=pdf\">here</a>.</li>\r\n\t<li>The <strong>Therapeutic Development Award </strong>supports research ranging from preclinical validation of therapeutic leads through FDA IND-enabling studies. The proposed studies are expected to be empirical in nature and product driven. Applicants with limited ALS experience are strongly encouraged to include collaborators with substantial experience in the relevant ALS model systems, endpoints, and pathophysiology. Candidate therapeutics that already have been granted an IND are not appropriate for the TDA.</li>\r\n\t<li>The <strong>Therapeutic Idea Award </strong>supports new, innovative, high-risk, high-gain ideas aimed at ALS drug or therapy discovery. The studies supported by this award mechanism are expected to be hypothesis-driven and generate preliminary data for future avenues of therapeutic investigation.</li>\r\n</ul>\r\n<strong>Funding</strong>: \r\n\r\n<ul>\r\n\t<li>Clinical Outcomes and Biomarkers Award: max. $1M</li>\r\n\t<li>Pilot Clinical Trial Award: max. $2.8M</li>\r\n\t<li>Therapeutic Development Award: max. $2M</li>\r\n\t<li>Therapeutic Idea Award: max. $840K</li>\r\n</ul>\r\n<sup>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sup><br>\r\n<br>\r\n<strong>Duration</strong>: \r\n\r\n<ul>\r\n\t<li>Clinical Outcomes and Biomarkers Award: 3 years</li>\r\n\t<li>Pilot Clinical Trial Award: 3 years</li>\r\n\t<li>Therapeutic Development Award: 3 years</li>\r\n\t<li>Therapeutic Idea Award: 2 years</li>\r\n</ul>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 24 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>30 September 2026</strong>, 11:59 p.m Eastern Time<br>\r\n<br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=707101\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36241278&fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:[email protected]\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Clinical Outcomes and Biomarkers Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35925310&fileType=pdf\">HT942526ALSRPCOBA</a></li>\r\n\t\t<li>Pilot Clinical Trial Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35927287&fileType=pdf\">HT942526ALSRPPCTA</a></li>\r\n\t\t<li>Therapeutic Development Award : <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35921227&fileType=pdf\">HT942526ALSRPTDA</a></li>\r\n\t\t<li>Therapeutic Idea Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=35919305&fileType=pdf\">HT942526ALSRPTIA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>", "image_description": "", "creation_date": "2026-05-26T19:57:31", "last_modification_date": "2026-05-26T19:57:31", "link_label": "", "link_url": "", "canceled": "False", "cancel_reason": "", "place_and_room": "", "url_place_and_room": "", "url_online_room": "", "spoken_languages": [ "https://memento.epfl.ch/api/v1/spoken_languages/2/?format=api" ], "speaker": "", "organizer": "", "contact": "<a href=\"mailto:[email protected]\">Research Office</a>", "is_internal": "False", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 3, "fr_label": "Entrée libre", "en_label": "Free" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120862/", "category": { "id": 16, "code": "PROP", "fr_label": "Appel à proposition", "en_label": "Call for proposal", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/140/?format=api" ] }, { "id": 71950, "title": "U.S. CDMRP – Peer Reviewed Cancer Research Program | Research Funding", "slug": "us-cdmrp-peer-reviewed-cancer-research-program-res", "event_url": "https://memento.epfl.ch/event/us-cdmrp-peer-reviewed-cancer-research-program-res", "visual_url": "https://memento.epfl.ch/image/33258/200x112.jpg", "visual_large_url": "https://memento.epfl.ch/image/33258/720x405.jpg", "visual_maxsize_url": "https://memento.epfl.ch/image/33258/max-size.jpg", "lang": "en", "start_date": "2026-06-26", "end_date": "2026-06-26", "start_time": null, "end_time": null, "description": "<strong>Aim</strong>: Through the Congressionally Directed Medical Research Program (CDMRP), the Department of Defense is announcing the 2026 <strong>Peer Reviewed Cancer Research Program (PRCRP). </strong>Several award programs are available:\r\n<ul>\r\n\t<li>The <strong>Idea Award </strong>supports innovative, untested, high-risk/potentially high-reward concepts, theories, paradigms, and/or basic cancer research. The advancement of knowledge in cancer research, patient care, and/or treatment options in the Military Health System (MHS) is critical to active-duty Service Members, Veterans, other military beneficiaries, and the American public.</li>\r\n\t<li>The <strong>Impact Award</strong> supports mature research that will have a near-term impact on clinical cancer care in one of the Topic Areas. Applicants must consider how the research project will lead to the advancement of knowledge in cancer research, patient care and/or treatment options in the MHS.</li>\r\n\t<li>The <strong>Clinical Trial Award </strong>supports the rapid implementation of clinical trials with the potential to have a significant impact on the treatment or management of cancer within at least one of the Topic Areas. Clinical trials proposed may evaluate promising new products, pharmacologic agents (drugs or biologics), devices, clinical guidance, and/or emerging approaches and technologies. Proposed projects may range from small proof-of-concept trials (e.g., pilot, first-in-human, phase 0) that evaluate the effects of interventions or inform the design of more advanced trials to large-scale trials (up to phase III) to determine efficacy in relevant patient populations.</li>\r\n</ul>\r\nAll applications must specifically address at least one of the <strong>Topic Areas. </strong>The FY26 PRCRP Topic Areas are listed at the end of this announcement.<br>\r\n<br>\r\n<strong>Funding</strong>: <br>\r\n<strong>Idea Award</strong>: max. $600K<br>\r\n<strong>Impact Award</strong>: $1.5M-$2M<br>\r\n<strong>Clinical Trial Award</strong>: max. $4.5M<br>\r\n<sup>Note: Cost caps are <strong>total costs (direct plus indirect costs). </strong>In accordance with EPFL guidelines, budgets should include a 20% overhead, and the total budget must remain within the grant’s maximum allowable funding</sup><br>\r\n<br>\r\n<br>\r\n<strong>Duration</strong>: <br>\r\n<strong>Idea Award</strong>: 2 years<br>\r\n<strong>Impact Award</strong>: 3 years<br>\r\n<strong>Clinical Trial Award: </strong>4 years<br>\r\n<br>\r\n<strong>Eligibility: </strong>Applicants from international organizations or institutions are eligible to apply, and there are no citizenship restrictions. Independent investigators at all career levels are eligible.<br>\r\n<br>\r\n<strong>How to Apply</strong>: Pre-applications are submitted through the <a href=\"https://ebrap.org/eBRAP/public/index.htm\">eBRAP platform</a>. They should contain contact information, a letter of intent, and a list of collaborators and key personnel as suggested on the platform. Full applications will be made via a Grants.gov workspace.<br>\r\n<br>\r\n<strong>Pre-Application Deadline: 26 June 2026, </strong>5:00 p.m. Eastern time<br>\r\n<strong>Full Application Deadline</strong>: <strong>05 October 2026</strong>, 11:59 p.m Eastern Time<br>\r\n <br>\r\n<strong>Further information:</strong>\r\n\r\n<ul>\r\n\t<li>To find the full program announcements and to start your pre-application see <a href=\"https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719105\">here</a></li>\r\n\t<li>A useful summary of each call can be found <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36245281&fileType=pdf\">here</a></li>\r\n\t<li>For questions about the eBRAP or Grants.gov platforms, contact the <a href=\"mailto:[email protected]\">Research Office</a>.</li>\r\n\t<li>Grants.gov Funding Opportunity Numbers:\r\n\t<ul>\r\n\t\t<li>Idea Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235224&fileType=pdf\">HT942526PRCRPIA</a></li>\r\n\t\t<li>Impact Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235237&fileType=pdf\">HT942526PRCRPIPA</a></li>\r\n\t\t<li>Clinical Trial Award: <a href=\"https://ebrap.org/eBRAP/public/ViewFile.htm?fileId=36235233&fileType=pdf\">HT942526PRCRPCTA</a></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n<strong>FY26 </strong><strong>PRCRP Topic Areas:</strong><br>\r\nBladder cancer • Blood cancers • Brain cancer • Colorectal cancer • Endometrial cancer • Esophageal cancer • Germ cell cancers • Glioblastoma • Liver cancer • Lymphoma • Mesothelioma • Metastatic cancers • Myeloma • Neuroblastoma • Neuroendocrine Tumors • Pediatric, adolescent, and young adult cancers1 • Pediatric brain tumors • Sarcoma • Stomach cancer • Thyroid cancer<br>\r\n ", "image_description": "", "creation_date": "2026-05-26T20:48:08", "last_modification_date": "2026-05-26T20:48:08", "link_label": "", "link_url": "", "canceled": "False", "cancel_reason": "", "place_and_room": "", "url_place_and_room": "", "url_online_room": "", "spoken_languages": [ "https://memento.epfl.ch/api/v1/spoken_languages/2/?format=api" ], "speaker": "", "organizer": "", "contact": "<a href=\"mailto:[email protected]\">Research Office</a>", "is_internal": "False", "theme": "", "vulgarization": { "id": 1, "fr_label": "Tout public", "en_label": "General public" }, "registration": { "id": 3, "fr_label": "Entrée libre", "en_label": "Free" }, "keywords": "", "file": null, "icalendar_url": "https://memento.epfl.ch/event/export/120863/", "category": { "id": 16, "code": "PROP", "fr_label": "Appel à proposition", "en_label": "Call for proposal", "activated": true }, "academic_calendar_category": null, "domains": [], "mementos": [ "https://memento.epfl.ch/api/v1/mementos/9/?format=api", "https://memento.epfl.ch/api/v1/mementos/140/?format=api" ] } ] }
